![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Creates Coronavirus Treatment Acceleration Program
FDA Creates Coronavirus Treatment Acceleration Program
![IV patient and doctor](https://www.fdanews.com/ext/resources/test/Drug-Images4/IV-blood-patient-nurse-doctor.gif?t=1585694898&width=430)
March 31, 2020
The FDA launched the Coronavirus Treatment Acceleration Program (CTAP), an emergency program for potential COVID-19 therapies.
The agency has deployed staff specifically to reviewing COVID-19 therapies.
The agency is currently monitoring 10 therapies in active trials and 15 others in planning stages.
Upcoming Events
-
21Oct